Biologics in pediatric psoriasis - efficacy and safety.

about

Biologics in pediatric psoriasis - efficacy and safety.

Item

http://www.wikidata.org/entity/Q42696430

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Biologics in pediatric psoriasis - efficacy and safety.

@en

Biologics in pediatric psoriasis - efficacy and safety.

@nl

type

Item

label

Biologics in pediatric psoriasis - efficacy and safety.

@en

Biologics in pediatric psoriasis - efficacy and safety.

@nl

prefLabel

Biologics in pediatric psoriasis - efficacy and safety.

@en

Biologics in pediatric psoriasis - efficacy and safety.

@nl

P1476

Biologics in pediatric psoriasis - efficacy and safety

@en

P2093

Sunil Dogra

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-TNF agents for paediatric psoriasis

Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview

Biologics and Pediatric Generalized Pustular Psoriasis: An Emerging Therapeutic Trend

Systemic Treatment of Pediatric Psoriasis: A Review

Epidemiology of skin diseases in school children: a study from northern India

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.

The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials.

Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms.

Japanese guidance for use of biologics for psoriasis (the 2013 version).

P304

9-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14740338.2018.1391787

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rahul Mahajan

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29022425

http://www.w3.org/2001/XMLSchema#string